1-12 of 12
Antoine Saliba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 Multicenter, Open-Label Study of CTX-712 in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes

Aref Al-Kali, Antoine Saliba, Cecilia Y. Arana Yi, James M. Foran, Yasushi Tanoue, Maki Yamamoto, Joachim Gullbo, Guillermo Garcia-Manero
Journal: Blood
Blood (2023) 142 (Supplement 1): 3249.
https://doi.org/10.1182/blood-2023-173496
Published: 2023
Journal Articles

STAG2 and PHF6 : Comparison of 2 X-Linked Gene Mutations in Myeloid Neoplasms

Bahga Katamesh, Amrutha Mittapalli, Rong He, David Viswanatha, Dragan Jevremovic, Mehrdad Hefazi, Antoine Saliba, Abhishek A Mangaonkar, Kebede Begna, William J. Hogan, Naseema Gangat, Mrinal M. Patnaik, Mithun V Shah, Ayalew Tefferi, Mark R. Litzow, Hassan Alkhateeb, Aref Al-Kali
Journal: Blood
Blood (2023) 142 (Supplement 1): 4304.
https://doi.org/10.1182/blood-2023-178244
Published: 2023
Journal Articles

Comparable Survival of Treatment Naïve TP53 Mutated Acute Myeloid Leukemia Treated with Hypomethylating Agent Compared to Hypomethylating Agent Plus Venetoclax Based Therapy

Talha Badar, Ehab L. Atallah, Rory M. Shallis, Anand Ashwin Patel, Guilherme Sacchi De Camargo Correia, Aaron D. Goldberg, Antoine Saliba, Jan Philipp Bewersdorf, Adam S Duvall, Danielle Bradshaw, Yasmin Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Vamsi K. Kota, Mark R. Litzow
Journal: Blood
Blood (2023) 142 (Supplement 1): 592.
https://doi.org/10.1182/blood-2023-184626
Published: 2023
Journal Articles

Venetoclax (VEN) Improves Response Rates but Not Survival in Patients with Chronic Myelomonocytic Leukemia (CMML) Treated with Hypomethylating Agents (HMA): A Multicenter, Propensity Score Analysis

Douglas Tremblay, Clifford M Csizmar, Courtney D. DiNardo, Somedeb Ball, Noa Rippel, Danielle E. Hammond, Tapan M. Kadia, Farhad Ravandi, Kelly S. Chien, Grace Van Hyfte, Antoine Saliba, Abhishek A Mangaonkar, Terra L Lasho, Aref Al-Kali, Marina Kremyanskaya, Jonathan Feld, Lewis R Silverman, Rami S. Komrokji, John Mascarenhas, Eric Padron, Guillermo Garcia-Manero, David A Sallman, Mrinal M. Patnaik, Guillermo Montalban-Bravo
Journal: Blood
Blood (2023) 142 (Supplement 1): 321.
https://doi.org/10.1182/blood-2023-181795
Published: 2023
Journal Articles

Venetoclax + Cladribine + Low-Dose Cytarabine in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax + Hypomethylating Agent

Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Animesh D. Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Cecilia Y. Arana Yi, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 2853.
https://doi.org/10.1182/blood-2023-185185
Published: 2023
Journal Articles

Survival and Prognosis Among 301 Patients with Newly-Diagnosed Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy

Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla Johnson, Maymona Abdelmagid, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Mrinal M. Patnaik, Animesh D. Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y. Arana Yi, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 591.
https://doi.org/10.1182/blood-2023-178837
Published: 2023
Journal Articles

ELN 2022 Favorable Genetic Risk Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agent: Predictors of Response and Survival

Kristen McCullough, Omer Karrar, Moazah Iftikhar, Maymona Abdelmagid, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Mrinal M. Patnaik, Animesh D. Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 5925.
https://doi.org/10.1182/blood-2023-182326
Published: 2023
Journal Articles

Impact of Diagnosis-to-Treatment Interval on Overall Survival in Patients with Mantle Cell Lymphoma: A National Cancer Database Analysis

Xavier Andrade-Gonzalez, Allison M. Bock, Jacqueline Wang, Antoine Saliba, Javier Munoz, David J. Inwards, Jonas Paludo, Thomas M. Habermann, Grzegorz S. Nowakowski, Yucai Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3549.
https://doi.org/10.1182/blood-2021-151952
Published: 2021
Journal Articles

Multicenter Analysis of Treatment and Outcomes for Patient with TP53 Mutated AML in the Era of Novel Therapies; Significant Impact of Allogeneic Stem Cell Transplantation on Survival

Talha Badar, Mark R. Litzow, Rory M. Shallis, Jan Philipp Bewersdorf, Antoine Saliba, Guilherme sacchi De Camargo Correia, Maximilian Stahl, Aaron D Goldberg, Ehab L. Atallah, James M. Foran
Journal: Blood
Blood (2021) 138 (Supplement 1): 797.
https://doi.org/10.1182/blood-2021-147639
Published: 2021
Journal Articles

Influence of Treatment Facility Type and Annual Patient Volume on Overall Survival in Patients with Mantle Cell Lymphoma: A National Cancer Database Analysis

Xavier Andrade-Gonzalez, Anuhya Kommalapati, Allison M. Bock, Jacqueline Wang, Antoine Saliba, Javier Munoz, David J. Inwards, Jonas Paludo, Thomas M. Habermann, Grzegorz S. Nowakowski, Yucai Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1348.
https://doi.org/10.1182/blood-2021-151888
Published: 2021
Journal Articles

Treatment Outcome for Symptomatic Patients with Clonal Cytopenia of Undetermined Significance: A Single-Institution Retrospective Study

Zhuoer Xie, MD, Ahmad Nanaa, Antoine Saliba, MD, Rong He, MD, Phuong L. Nguyen, MD, Dragan Jevremovic, MD PhD, Patricia Greipp, DO, Mohamed Salama, MD, Naseema Gangat, MBBS, Hassan B. Alkhateeb, MD, Ayalew Tefferi, MD, Mark Litzow, MD, Mrinal M. Patnaik, MDMBBS, Mithun Vinod Shah, MD PhD, Aref Al-Kali, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44.
https://doi.org/10.1182/blood-2020-137527
Published: 2020
Journal Articles

Immune-Related Hematologic Adverse Events in the Context of Checkpoint Inhibitors

Antoine Saliba, MD, Zhuoer Xie, MD, Ally Higgins, MD, Xavier A Andrade-Gonzalez, MD, Harry E Fuentes-Bayne, MD, Paul J. Hampel, MD, Lionel Kankeu Fonkoua, MD, Daniel Childs, MD, Sagar Rakshit, MD, Evandro D. Bezerra, MD, Yanyan Lou, MD, Candido E. Rivera, MD, Katharine Price, MD, Yiyi Yan, MD PhD, Anna Schwecke, MS, APRN, CNP, Matthew S. Block, MD PhD, Uma Thanarajasingam, MD, PhD, Gita Thanarajasingam, MD, Alexandra P. Wolanskyj, MD, Ariela L. Marshall, MD, Lisa A Kottschade, APRN, CNP, Ronald S. Go, MD, Aref Al-Kali, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-138657
Published: 2020